Learning Center
About Us
Catheter Securement Choice Does Affect Central Line-Associated Bloodstream Infection Risk. The SecurAcath device significantly reduces CLABSI risk. A recent study published in AJIC* showed an adhesive catheter securement device had a 288% increase in risk of CLABSI compared to the SecurAcath. CLABSIs yield tremendous negative consequences affecting patients and health care facilities globally. The CDC estimates the annual cost of CLABSI in the U.S. is more than $1 billion. SecurAcath decreases CLABSI risk, dramatically reduces catheter dislodgements and replacements, and lowers the total cost of patient care. Make the switch to the only subcutaneous catheter securement device today!
*Rowe, et al. AJIC, Open Access June 17, 2020
